Philippe Billiald

Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab

Christine Voors‐Pette, Kristell Lebozec, Peter Dogterom et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 116 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +8

Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks

Kristell Lebozec, Martine Jandrot‐Perrus, Gilles Avenard et al. · mAbs · 2017 · 92 citations · Full text

Medicine, Hematology, Pharmacology +17

Non-Invasive Molecular Imaging of Fibrosis Using a Collagen-Targeted Peptidomimetic of the Platelet Collagen Receptor Glycoprotein VI

Julien Muzard, Laure Sarda‐Mantel, Stéphane Loyau et al. · PLoS ONE · 2009 · 91 citations · Full text

Medicine, Molecular Biology, Pathology +17

Construction and functional evaluation of a single‐chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion <i>Androctonus australis hector</i>

Christiane Devaux, Emmanuel Moreau, M. Goyffon et al. · European Journal of Biochemistry · 2001 · 64 citations

Pharmacy, Immunology, Molecular Biology +17

A recombinant single‐chain antibody fragment that neutralizes toxin II from the venom of the scorpion <i>Androctonus australis hector</i>

Mohamed Mousli, Christiane Devaux, Hervé Rochat et al. · FEBS Letters · 1999 · 58 citations

Pharmacy, Biotechnology, Molecular Biology +17